3-Amino-N-[9-(ethyl-methyl-amino)-5,9a-dihydroxy-9b-methyl-1,2,3,3a,8,9,9a,9b-octahydro-phenanthro[4,5-bcd]furan-3-yl]-succinamic acid

ID: ALA2112087

PubChem CID: 13894014

Max Phase: Preclinical

Molecular Formula: C21H27N3O6

Molecular Weight: 417.46

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(NC(=O)C(N)CC(=O)O)CC[C@@]3(O)[C@H]1C5

Standard InChI:  InChI=1S/C21H27N3O6/c1-24-7-6-20-16-10-2-3-13(25)17(16)30-18(20)12(4-5-21(20,29)14(24)8-10)23-19(28)11(22)9-15(26)27/h2-3,11-12,14,18,25,29H,4-9,22H2,1H3,(H,23,28)(H,26,27)/t11?,12?,14-,18+,20+,21-/m1/s1

Standard InChI Key:  LXMHWYGUOLGVMF-KXALCDBTSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  1  0  0  0  0  0999 V2000
    8.6820   -3.1196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6638   -2.2760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9762   -3.5581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4101   -3.5175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9893   -4.3848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0042   -4.2601    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9229   -1.8758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2335   -3.1523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6072   -3.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2041   -2.3121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1289   -3.0813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8772   -3.4854    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3681   -4.2953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3680   -1.8318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3443   -3.4533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1085   -4.7140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2818   -4.8177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2300   -1.0089    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5148   -3.5886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1163   -2.2360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5818   -2.1982    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0197   -1.2836    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.8409   -4.2614    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5386   -4.4306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0693   -2.9968    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1397   -5.5600    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3051   -5.6784    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5145   -1.4563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8073   -0.3872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8601   -2.9221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1330   -4.2084    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.1471   -1.2448    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  1  1  0
  5  3  2  0
  4  6  1  0
  7  2  1  0
  8  3  1  0
  9 12  1  0
 10  8  1  0
 11  4  1  0
 12 11  1  0
 13 15  1  0
 14  2  1  0
 15  9  1  0
 16 13  1  0
 17  5  1  0
 18  7  1  0
 19  8  2  0
 20 11  1  0
 21  9  2  0
  2 22  1  1
 23 16  2  0
 24 19  1  0
  1 30  1  1
 25 15  1  0
 26 16  1  0
 27 17  1  0
 28 18  1  0
 29 18  1  0
 30 28  1  0
  6  5  1  0
 14 20  1  0
  7 10  1  0
 17 24  2  0
  4 31  1  1
  7 32  1  6
M  END

Associated Targets(Human)

OPRK1 Tclin Opioid receptors; mu/kappa/delta (568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 417.46Molecular Weight (Monoisotopic): 417.1900AlogP: -0.54#Rotatable Bonds: 4
Polar Surface Area: 145.35Molecular Species: ZWITTERIONHBA: 7HBD: 5
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.41CX Basic pKa: 8.95CX LogP: -3.67CX LogD: -4.41
Aromatic Rings: 1Heavy Atoms: 30QED Weighted: 0.44Np Likeness Score: 1.63

References

1. Botros S, Lipkowski AW, Larson DL, Stark PA, Takemori AE, Portoghese PS..  (1989)  Opioid agonist and antagonist activities of peripherally selective derivatives of naltrexamine and oxymorphamine.,  32  (9): [PMID:2475628] [10.1021/jm00129a009]

Source